» Articles » PMID: 36685627

Evaluation of the Relationship Between Acute Kidney Injury and Renin Angiotensin System Inhibition in COVID-19 Patients

Overview
Publisher Kare Publishing
Specialty General Medicine
Date 2023 Jan 23
PMID 36685627
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In patients with coronavirus disease 2019 (COVID-19), acute kidney injury (AKI) may alter the clinical course and outcome of the disease. In this study, the association of AKI with renin angiotensin system (RAS) inhibitor treatment and its clinical consequences were examined in COVID-19 patients admitted to our hospital during the initial stages of the pandemic.

Methods: A total of 407 patients between 18 and 85 years of age (202 male and 205 female) admitted to the Umraniye Research And Training Hospital between May 2020 and August 2020 with a diagnosis of COVID-19 were included in the study. Patients were categorized as follows: Group 1, subjects with no chronic conditions (n=150); and Group 2, subjects with comorbid conditions (n=257). Group 2 was subdivided into Group 2A (receiving angiotensin receptor blocker [ARB])/(angiotensin converting enzyme inhibitor [ACEI], n=81), and Group 2B (not receiving ARB/ACEI, n=176).

Results: Hypertension was the most frequent comorbid condition (36.4%). There was no difference in survival rates between the patients who used RAS inhibitor and the ones who did not based on log rank test (p=0.342). Fifty-four patients (13.4%) had developed AKI during the time frame of the disease. In patients with chronic diseases such as hypertension, the use of RAS inhibitory medication was not associated with developing AKI (OR 95% CI: 0.317-1.358; p=0.256). The survival rate of the patients with AKI was significantly lower than patients without AKI (p<0.0001).

Conclusion: COVID-19 may cause renal injury represents a risk factor for mortality. Therefore, detection of renal injury has a particular prognostic importance.

References
1.
Golmai P, Larsen C, DeVita M, Wahl S, Weins A, Rennke H . Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19. J Am Soc Nephrol. 2020; 31(9):1944-1947. PMC: 7461690. DOI: 10.1681/ASN.2020050683. View

2.
Hansrivijit P, Gadhiya K, Gangireddy M, Goldman J . Risk Factors, Clinical Characteristics, and Prognosis of Acute Kidney Injury in Hospitalized COVID-19 Patients: A Retrospective Cohort Study. Medicines (Basel). 2021; 8(1). PMC: 7825666. DOI: 10.3390/medicines8010004. View

3.
Tang N, Li D, Wang X, Sun Z . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4):844-847. PMC: 7166509. DOI: 10.1111/jth.14768. View

4.
Fosbol E, Butt J, Ostergaard L, Andersson C, Selmer C, Kragholm K . Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality. JAMA. 2020; 324(2):168-177. PMC: 7305566. DOI: 10.1001/jama.2020.11301. View

5.
Rudiansyah M, Lubis L, Bandiara R, Supriyadi R, Afiatin , Gondodiputro R . Java Barb Fish Gallbladder-Induced Acute Kidney Injury and Ischemic Acute Hepatic Failure. Kidney Int Rep. 2020; 5(5):751-753. PMC: 7210697. DOI: 10.1016/j.ekir.2020.03.014. View